ArticleJournal of pediatrics. Clinical practice2025
Physician Practices, Attitudes, and Challenges Related to Pediatric COVID-19 Vaccination in the United States.
Article in Journal of pediatrics. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infant Respiratory Syncytial Virus Immunization Through Maternal Vaccination and Nirsevimab.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess physician practices, attitudes, and challenges related to pediatric COVID-19 vaccination in the United States. Methods: An online survey of 102 pediatricians and 104 family medicine physicians who serve pediatric patients in the United States was conducted during August 15-16, 2023, using an opt-in internet survey panel. Results: The majority (86.3%) of physicians reported that their office had ever offered COVID-19 vaccination, and among those that had ever offered it, 91.7% reported currently offering it to some or all pediatric patients aged 6 months-17 years old. Slightly more than half (54.8%) of physicians strongly agreed and 32.0% agreed with the statement, "I believe COVID-19 vaccine is generally safe for children," and about 84% strongly agreed or agreed that benefits of pediatric COVID-19 vaccination outweighed possible risks and side effects of the vaccine and inconveniences. The top 3 identified challenges of offering COVID-19 vaccination to pediatric patients were 1) lack of demand from parents (48.8%), 2) different vaccine products/formulations for different age groups (37.1%), and 3) large minimum package size/large number of doses per vial (32.9%). Slightly more than 80% strongly agreed or agreed with the statement, "I believe that pharmacies can serve as an important place for COVID-19 vaccination of school-aged children." Conclusions: Most physicians reported offering the COVID-19 vaccine to their pediatric patients but reported that low parental demand posed challenges to achieving high pediatric COVID-19 vaccination coverage. Although physician confidence in COVID-19 vaccine safety was fairly high overall, improved confidence may increase the likelihood of a strong physician recommendation, leading to higher parental demand and uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.